-
Concerned About The Election? Take Profits Off The Table Now, Strategist Says
Monday, October 12, 2020 - 9:50am | 349Read More...The U.S. presidential election is weeks away, and there will be "surprises here and there" that could add new volatility to the markets, B. Riley FBR Chief Global Market Strategist Mark Grant said Monday on CNBC's "Squawk Box." What Happened: The presidential election is...
-
Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race
Tuesday, May 26, 2020 - 3:37pm | 568Read More...Novavax, Inc. (NASDAQ: NVAX), which last month landed CEPI funding for its coronavirus vaccine program, announced Tuesday the initiation of human studies of its vaccine candidate, NVX-CoV2373. The Novavax Analysts Cantor Fitzgerald analyst Charles Duncan maintained an...
-
Mastercraft Boat Rides Upgrade After Analyst Is 'Increasingly Confident' Demand Is Intact
Monday, May 18, 2020 - 5:02pm | 335Read More...The COVID-19 pandemic's impact on the boating market may have been overstated as recent checks point to strengthening week-to-week demand and Mastercraft Boat Holdings Inc (NASDAQ: MCFT) should see a strong summer selling period, according to B. Riley FBR. The Mastercraft Boat Holdings Analyst...
-
Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development
Tuesday, May 12, 2020 - 2:08pm | 754Read More...Novavax, Inc. (NASDAQ: NVAX) announced Monday after the close an award of an incremental $384 million in funding by the Coalition for Epidemic Preparedness Innovations alongside forecast-beating first-quarter results. The Novavax Analysts H.C. Wainwright analyst Vernon Bernardino reiterated a Buy...
-
Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone
Friday, December 27, 2019 - 3:50pm | 400Read More...Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), which plummeted 60% to $3.50 Thursday in reaction to a negative clinical readout, were rebounding Friday. The Spectrum Pharma Analyst B Riley FBR analyst Mayank Mamtani maintained a Buy rating on Spectrum and lowered the price target from $...
-
Biotech Stock On The Radar: Immunomedics' Long Wait For Redemption
Wednesday, October 23, 2019 - 4:27pm | 1374Read More...Immunomedics, Inc. (NASDAQ: IMMU) is a biopharma company focusing on the development of antibody-drug conjugates, or ADCs. The Morris Plains, New Jersey-based company was founded in 1982 and has yet to market a commercial product. Its investigational therapies include ADCs that are...
-
The Street Debates What To Do With Yelp Stock After Q4 Beat
Thursday, February 14, 2019 - 12:25pm | 649Read More...The crowdsourced review platform Yelp Inc (NYSE: YELP) reported Wednesday with fourth-quarter results that easily beat expectations and said it expects revenue to grow at a mid-teens compounded annual growth rate through 2023. Here's how Yelp analysts on the Street reacted to the...
-
The Midterm Election: What 3 Pros Expect
Tuesday, November 6, 2018 - 1:05pm | 533Read More...American voters are headed to the polls Tuesday to decide the fate of Congressional elections, gubernatorial races, ballot proposals and more. The following are three expert takes ahead of the midterm results. Three 'Risks' With A Democratic Majority There are three...
-
Recent Assembly Biosciences Weakness Provides Attractive Entry Point, B Riley FBR Says In Upgrade
Monday, October 8, 2018 - 3:16pm | 385Read More...Assembly Biosciences Inc (NASDAQ: ASMB) shares have shed over one-fourth of their value since late September, creating an opportunity to buy the dip, B. Riley FBR said Monday. The Analyst Analyst Madhu Kumar upgraded shares of Assembly Biosciences from Neutral to Buy and reiterated a $42...
-
FBR: Novavax Looks Healthy Ahead Of Catalysts
Monday, October 8, 2018 - 10:26am | 403Read More...As Novavax, Inc. (NASDAQ: NVAX) approaches two key dates in its pipeline, bulls are preparing to profit. The Rating B Riley FBR analysts George Zavoico and Dylan Dupuis maintained a Buy rating on Novavax with a $10 price target. The Thesis The biotech will complete two clinical trials in the first...
-
Ahoy, Upside Ahead: B Riley FBR Out Bullish On 3 Shipping Stocks
Thursday, October 4, 2018 - 2:31pm | 710Read More...B. Riley FBR initiated coverage of multiple shipping stocks this week, taking bullish stances on Scorpio Bulkers Inc (NYSE: SALT), 2) Golar LNG Limited (NASDAQ: GLNG) and Eagle Bulk Shipping Inc. (NASDAQ: EGLE). The Analyst B. Riley FBR's Liam Burke initiated coverage of three...
-
Analysts React To Weight Watcher's Q2 Earnings
Tuesday, August 7, 2018 - 1:29pm | 562Read More...Weight Watchers International, Inc. (NYSE: WTW) reported an earnings beat in its second-quarter results, which may have been overshadowed by a slowdown in subscriber growth. Here's a summary of how some Street analysts reacted to the report. The Analysts D.A. Davidson's Linda Bolton Weiser...
-
Pluristem Therapeutics, Rexahn Pharma Are Biotech Winners, B Riley FBR Says In Bullish Initiation
Tuesday, July 31, 2018 - 3:16pm | 522Read More...With hundreds of biotech stocks all assuring big prospects, building a portfolio of truly transformative medicine makers is a feat. B. Riley FBR said it's found two winners. The Analyst Analyst George Zavoico initiated coverage of Pluristem Therapeutics Inc. (NASDAQ: PSTI)...
-
Columbia Sportswear Downgraded Ahead Of Q2 Print
Wednesday, July 18, 2018 - 3:38pm | 354Read More...Columbia Sportswear Company (NASDAQ: COLM) continues to boast a strong brand portfolio but after strong gains in the stock over the past year the valuation is now "stretched." The Analyst B. Riley FBR's Susan Anderson downgraded Columbia Sportswear from Buy to Neutral but with a...
-
Farmland Partners Loans Are 'Concerning, But Immaterial,' Analyst Says In Upgrade
Thursday, July 12, 2018 - 4:35pm | 456Read More...Farmland Partners Inc (NYSE: FPI) dropped 39 percent Wednesday on negative rumors about its loan program, solvency, valuation and reliance on external sources of capital, among other factors. The Analyst B. Riley FBR analyst Craig Kucera upgraded Farmland Partners from Neutral to Buy and cut...
